Highlight transcript below to create clipTranscript: Print | Email Go Click text to jump within videoWed 23 Jan 13 | 05:30 AM ET Ken Frazier, CEO of Merck, tells CNBC about the challenges of finding new blockbuster drugs and how any change to Medicare funding must have a sustainable benefit.
Saturday, February 16, 2013
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment